Literature DB >> 33802085

The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still's Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets.

Ilenia Di Cola1, Piero Ruscitti1, Roberto Giacomelli2, Paola Cipriani1.   

Abstract

Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown aetiology affecting young adults, which is burdened by life-threatening complications, mostly macrophage activation syndrome (MAS). Interferons (IFNs) are signalling molecules that mediate a variety of biological functions from defence against viral infections, to antitumor and immunomodulatory effects. These molecules have been classified into three major types: IFN I, IFN II, IFN III, presenting specific characteristics and functions. In this work, we reviewed the role of IFNs on AOSD and MAS, focusing on their pathogenic role in promoting the hyperinflammatory response and as new possible therapeutic targets. In fact, both preclinical and clinical observations suggested that these molecules could promote the hyperinflammatory response in MAS during AOSD. Furthermore, the positive results of inhibiting IFN-γ in primary hemophagocytic lymphohistiocytosis may provide a solid rationale to arrange further clinical studies, paving the way for reducing the high mortality rate in MAS during AOSD.

Entities:  

Keywords:  IFN-γ; adult-onset Still’s disease; macrophage activation syndrome

Year:  2021        PMID: 33802085      PMCID: PMC7999936          DOI: 10.3390/jcm10061164

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  66 in total

Review 1.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

Authors:  S Goodbourn; L Didcock; R E Randall
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

2.  Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome.

Authors:  Maria F Ibarra; Marisa Klein-Gitelman; Elaine Morgan; Maria Proytcheva; Christine Sullivan; Gabrielle Morgan; Lauren M Pachman; Maurice R G O'Gorman
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

Review 3.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

4.  Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.

Authors:  Piero Ruscitti; Daniela Iacono; Francesco Ciccia; Giacomo Emmi; Paola Cipriani; Rosa Daniela Grembiale; Federico Perosa; Lorenzo Emmi; Giovanni Triolo; Roberto Giacomelli; Gabriele Valentini
Journal:  J Rheumatol       Date:  2018-04-15       Impact factor: 4.666

5.  IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1.

Authors:  R Schindler; P Ghezzi; C A Dinarello
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

6.  Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series.

Authors:  Sarah Hansen; Waleed Alduaij; Catherine M Biggs; Sara Belga; Kai Luecke; Hayley Merkeley; Luke Y C Chen
Journal:  Eur J Haematol       Date:  2021-02-17       Impact factor: 2.997

7.  Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?

Authors:  Piero Ruscitti; Onorina Berardicurti; Antonio Barile; Paola Cipriani; Yehuda Shoenfeld; Annamaria Iagnocco; Roberto Giacomelli
Journal:  Ann Rheum Dis       Date:  2020-05-20       Impact factor: 19.103

8.  Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.

Authors:  Rupali Das; Peng Guan; Leslee Sprague; Katherine Verbist; Paige Tedrick; Qi Angel An; Cheng Cheng; Makoto Kurachi; Ross Levine; E John Wherry; Scott W Canna; Edward M Behrens; Kim E Nichols
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

Review 9.  Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm.

Authors:  Piero Ruscitti; Onorina Berardicurti; Paola Di Benedetto; Paola Cipriani; Annamaria Iagnocco; Yehuda Shoenfeld; Roberto Giacomelli
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

10.  A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis.

Authors:  Qing Zhang; Ang Wei; Hong-Hao Ma; Li Zhang; Hong-Yun Lian; Dong Wang; Yun-Ze Zhao; Lei Cui; Wei-Jing Li; Ying Yang; Tian-You Wang; Zhi-Gang Li; Rui Zhang
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

View more
  7 in total

1.  The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.

Authors:  Piero Ruscitti; Onorina Berardicurti; Ilenia Di Cola; Claudia Di Muzio; Elena Di Nino; Roberto Giacomelli; Paola Cipriani
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

2.  The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.

Authors:  Piero Ruscitti; Onorina Berardicurti; Ilenia Di Cola; Claudia Di Muzio; Elena Di Nino; Roberto Giacomelli; Paola Cipriani
Journal:  Clin Exp Immunol       Date:  2022-02-02       Impact factor: 5.732

3.  The difference of the inflammatory milieu in MIS-C and severe COVID-19.

Authors:  Sibel Lacinel Gurlevik; Yasemin Ozsurekci; Erdal Sağ; P Derin Oygar; Selman Kesici; Ümmüşen Kaya Akca; Muserref Kasap Cuceoglu; Ozge Basaran; Sultan Göncü; Jale Karakaya; Ali Bülent Cengiz; Seza Özen
Journal:  Pediatr Res       Date:  2022-03-29       Impact factor: 3.756

Review 4.  Activation mechanisms of monocytes/macrophages in adult-onset Still disease.

Authors:  Hiroto Tsuboi; Seiji Segawa; Mizuki Yagishita; Hirofumi Toko; Fumika Honda; Ayako Kitada; Haruka Miki; Ayako Ohyama; Shinya Hagiwara; Yuya Kondo; Isao Matsumoto; Takayuki Sumida
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

Review 5.  New insights on multigenic autoinflammatory diseases.

Authors:  Petros Efthimiou; Olga Petryna; Priscila Nakasato; Apostolos Kontzias
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-03       Impact factor: 3.625

Review 6.  Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases.

Authors:  Adam Al-Hakim; Anoop Mistry; Sinisa Savic
Journal:  J Inflamm Res       Date:  2022-10-10

Review 7.  An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.

Authors:  Po-Ku Chen; Der-Yuan Chen
Journal:  J Immunol Res       Date:  2021-06-20       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.